{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-295456","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2023-12-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.822872+00:00","generated_at":"2026-06-07T12:50:40.312210+00:00","sec_items":["1.01","2.03"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Stoke Therapeutics extends headquarters lease to Dec 2026; aggregate rent ~$5.05M","bullets":["Entered first amendment to lease for corporate HQ and lab at 45-47 Wiggins Ave, Bedford, MA.","Lease term extended by two years to December 31, 2026.","Aggregate estimated base rent over extension period approximately $5.05 million.","Option to further extend for five years at 95% of then-prevailing market rate."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-295456","json":"https://secwatch.observer/filing/0001193125-23-295456.json","markdown":"https://secwatch.observer/filing/0001193125-23-295456.md","text":"https://secwatch.observer/filing/0001193125-23-295456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312523295456/0001193125-23-295456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312523295456/d523640d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T12:50:40.312210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"142c69ca79a2d7b988d407971f6b0ed3b3de3676","claim":"Stoke Therapeutics, Inc. amended First Amendment with Xenon Property, LLC valued at approximately $5.05 million (effective 2023-12-12).","evidence_excerpt":"On December 12, 2023, Stoke Therapeutics, Inc. (the “ Company ”) entered into a first amendment (the “ First Amendment ”) to its corporate headquarters and laboratory lease agreement with Xenon Property, LLC, as successor-in-interest to ARE-MA Region No. 24, LLC, located at 45-47 Wiggins Avenue, Bedford, Massachusetts (the “ Lease ”), in order to extend the term of the Lease for a period of two years (the “ Lease Extension Period ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1623526/000119312523295456/0001193125-23-295456-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"lease"},{"label":"Counterparty","value":"Xenon Property, LLC"},{"label":"Value","value":"approximately $5.05 million"},{"label":"Effective","value":"2023-12-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}